Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 8/20 | 0.40 |
| ▸ | ARSA | P15289 | 1/20 | 0.40 |
| ▸ | CDC25A | P30304 | 1/20 | 0.40 |
| ▸ | CDC25C | P30307 | 1/20 | 0.40 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.40 |
| ▸ | FYN | P06241 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | AHR | P35869 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | CYP1A1 | P04798 | 6/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 6/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | PRKDC | P78527 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27126291 | 1.00 | CYP1A2 (0.40) | CYP1A2ARSACDC25ACDC25CERBB2 | |
| SCHEMBL27126211 | 1.00 | CYP1A2 (0.40) | CYP1A2ARSACDC25ACDC25CERBB2 | |
| SCHEMBL27127221 | 0.97 | CYP1A2 (0.42) | CYP1A2ARSACDC25ACDC25CERBB2 | |
| SCHEMBL27126227 | 0.97 | CYP1A2 (0.42) | CYP1A2ARSACDC25ACDC25CERBB2 | |
| SCHEMBL27126297 | 0.96 | CYP1A2 (0.42) | CYP1A2ARSACDC25ACDC25CERBB2 | |
| SCHEMBL27126222 | 0.96 | CYP1A2 (0.42) | CYP1A2ARSACDC25ACDC25CERBB2 | |
| SCHEMBL27127041 | 0.96 | ARSA (0.45) | CYP1A2ARSACDC25ACDC25CERBB2 | |
| SCHEMBL27126246 | 0.94 | CYP1A2 (0.41) | CYP1A2ARSACDC25ACDC25CERBB2 | |
| SCHEMBL27127036 | 0.93 | ARSA (0.38) | CYP1A2ARSACDC25ACDC25CERBB2 | |
| SCHEMBL27126330 | 0.93 | CYP1A2 (0.46) | CYP1A2ARSACDC25ACDC25CERBB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240074311-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-02-29 | — | — | US | disclosed |
| US-20240074311-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-02-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240074311-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | RPS12, TCF12, RRP12 | CYP1A2 966/4885ARSA 1411/4885CDC25A 3107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.